Geode Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-694,798
| Closed | -$188K | – | 5019 |
|
|
2022
Q3 | $188K | Buy |
694,798
+15,297
| +2% | +$6.68K | ﹤0.01% | 4251 |
|
|
2022
Q2 | $523K | Sell |
679,501
-1,012
| -0.1% | -$902 | ﹤0.01% | 3736 |
|
|
2022
Q1 | $728K | Buy |
680,513
+50,507
| +8% | +$91.8K | ﹤0.01% | 3761 |
|
|
2021
Q4 | $1.2M | Buy |
630,006
+31,847
| +5% | +$76.3K | ﹤0.01% | 3630 |
|
|
2021
Q3 | $1.8M | Buy |
598,159
+137,404
| +30% | +$489K | ﹤0.01% | 3402 |
|
|
2021
Q2 | $1.8M | Sell |
460,755
-169,257
| -27% | -$702K | ﹤0.01% | 3309 |
|
|
2021
Q1 | $3.19M | Buy |
630,012
+318,875
| +102% | +$1.65M | ﹤0.01% | 3009 |
|
|
2020
Q4 | $1.27M | Buy |
311,137
+26,440
| +9% | +$130K | ﹤0.01% | 3288 |
|
|
2020
Q3 | $1.38M | Buy |
284,697
+5,957
| +2% | +$32.5K | ﹤0.01% | 3078 |
|
|
2020
Q2 | $1.54M | Buy |
278,740
+148,129
| +113% | +$678K | ﹤0.01% | 2979 |
|
|
2020
Q1 | $428K | Buy |
130,611
+43,678
| +50% | +$230K | ﹤0.01% | 3326 |
|
|
2019
Q4 | $392K | Hold |
86,933
| – | – | ﹤0.01% | 3583 |
|
|
2019
Q3 | $361K | Hold |
86,933
| – | – | ﹤0.01% | 3582 |
|
|
2019
Q2 | $329K | Buy |
86,933
+4,247
| +5% | +$17.4K | ﹤0.01% | 3617 |
|
|
2019
Q1 | $346K | Hold |
82,686
| – | – | ﹤0.01% | 3570 |
|
|
2018
Q4 | $205K | Buy |
82,686
+10,909
| +15% | +$63.9K | ﹤0.01% | 3668 |
|
|
2018
Q3 | $523K | Sell |
71,777
-19,679
| -22% | -$86.2K | ﹤0.01% | 3447 |
|
|
2018
Q2 | $338K | Sell |
91,456
-6,536
| -7% | -$30.2K | ﹤0.01% | 3560 |
|
|
2018
Q1 | $377K | Sell |
97,992
-10,959
| -10% | -$46.1K | ﹤0.01% | 3492 |
|
|
2017
Q4 | $392K | Sell |
108,951
-6,160
| -5% | -$23.3K | ﹤0.01% | 3452 |
|
|
2017
Q3 | $454K | Sell |
115,111
-41,451
| -26% | -$190K | ﹤0.01% | 3395 |
|
|
2017
Q2 | $798K | Sell |
156,562
-5,269
| -3% | -$29.6K | ﹤0.01% | 3186 |
|
|
2017
Q1 | $1.12M | Buy |
161,831
+15,575
| +11% | +$122K | ﹤0.01% | 2967 |
|
|
2016
Q4 | $1.37M | Buy |
146,256
+16,942
| +13% | +$153K | ﹤0.01% | 2838 |
|
|
2016
Q3 | $1.26M | Buy |
129,314
+8,765
| +7% | +$118K | ﹤0.01% | 2826 |
|
|
2016
Q2 | $1.7M | Buy |
120,549
+10,182
| +9% | +$159K | ﹤0.01% | 2579 |
|
|
2016
Q1 | $1.54K | Buy |
110,367
+18,077
| +20% | +$265K | ﹤0.01% | 2617 |
|
|
2015
Q4 | $1.88M | Buy |
92,290
+31,111
| +51% | +$480K | ﹤0.01% | 2529 |
|
|
2015
Q3 | $803K | Buy |
61,179
+14,030
| +30% | +$233K | ﹤0.01% | 2992 |
|
|
2015
Q2 | $723K | Buy |
47,149
+2,714
| +6% | +$52K | ﹤0.01% | 3052 |
|
|
2015
Q1 | $888K | Buy |
44,435
+798
| +2% | +$17.8K | ﹤0.01% | 2934 |
|
|
2014
Q4 | $917K | Buy |
43,637
+1,204
| +3% | +$24.5K | ﹤0.01% | 2902 |
|
|
2014
Q3 | $789K | Buy |
42,433
+21,399
| +102% | +$388K | ﹤0.01% | 2933 |
|
|
2014
Q2 | $485K | Buy |
+21,034
| New | +$371K | ﹤0.01% | 3183 |
|
Geode Capital Management's AGTC Position: Q4 2022 in Review
Geode Capital Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 694,798 shares — an estimated $188K sold.
Geode Capital Management first reported a position in AGTC in Q2 2014 and held it in 34 quarters. The position peaked at $3.19M in Q1 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Geode Capital Management reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Geode Capital Management sold 694,798 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $188K.
- Geode Capital Management first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 34 quarters.
- Geode Capital Management's Applied Genetic Technologies Corporation position peaked at $3.19M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.